Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...

Detaylı Bibliyografya
Asıl Yazarlar:	Pellagatti, A, Boultwood, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2016

Benzer Materyaller

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
Yazar:: Armstrong, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Gene expression profiling in the myelodysplastic syndromes.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
Yazar:: Johanna Flach, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

SF3B1 mutant myelodysplastic syndrome: Recent advances
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome
Yazar:: Julia C. Obenauer, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
Yazar:: Yip, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Clonality in the myelodysplastic syndromes.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

The impact of spliceosome mutations in MDS
Yazar:: Jacqueline Boultwood, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes
Yazar:: Marta Fernandez-Mercado, ve diğerleri
Baskı/Yayın Bilgisi: (2013-12-01)

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)
Yazar:: Steensma, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
Yazar:: Dolatshad, H, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Yazar:: Bernard, E, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
Yazar:: Liberante, F, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
Yazar:: Liberante, F, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Molecular pathogenesis of the myelodysplastic syndromes
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Discovering transcription and splicing networks in myelodysplastic syndromes.
Yazar:: Hongyan Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
Yazar:: Watkins, F, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Telomere length in myelodysplastic syndromes.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
Yazar:: Boultwood, J
Baskı/Yayın Bilgisi: (2009)

Structure of the granulocyte macrophage colony-stimulating factor gene in patients with the myelodysplastic syndromes.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
Yazar:: Iva Trsova, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
Yazar:: Boultwood, J
Baskı/Yayın Bilgisi: (2009)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
Yazar:: Zhang, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)